BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dynatronics Corporation (DYNT) Announces Fourth Quarter and Year-End Results


9/28/2012 10:22:57 AM

SALT LAKE CITY, Sept. 28, 2012 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT) today announced results for its fiscal fourth quarter and year ended June 30, 2012.

Net income for the quarter ended June 30, 2012, increased to $115,954 ($.01 per common share), compared to net income of $68,776 ($.01 per common share) for the same quarter in the prior fiscal year. Net loss for the year ended June 30, 2012, was $23,535 ($.00 per common share), compared to net income of $270,888 ($.02 per common share) for the year ended June 30, 2011.

Sales for the fiscal fourth quarter ended June 30, 2012, declined 5.5 percent to $7,738,363, compared to $8,190,383 for the quarter ended June 30, 2011. Sales for the year ended June 30, 2012, were $31,664,181, compared to $32,692,859 for the year ended June 30, 2011 representing a 3.1 percent decline.

"Fourth quarter profits improved despite a weakness in top-line sales," said Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "We were successful in reducing both SG&A and R&D costs to compensate for the sluggish markets we have been facing over the past three years. These operating improvements, combined with an income tax benefit related to R&D tax credits recorded during the fourth fiscal quarter, resulted in a net profit of $115,954 for the fourth quarter which was a significant turnaround from the net loss of $117,563 in the third quarter. Given ongoing economic weakness that was more pronounced in the last six months of the fiscal year, we have implemented strategies to help move the company forward despite such general economic concerns."

To combat the challenging economic trends, the company's strategic plan calls for the introduction of a record number of new products to spur interest in our most profitable segment of capital equipment and to position the company for growth.

"With last week's introduction of the SolarisPlus line of products, we are beginning to see renewed excitement among the sales force and increased interest in capital equipment purchases by customers," Cullimore continued. "This new line of electrotherapy, ultrasound and light therapy units represents our premier line of combination therapy devices and is attracting solid attention among practitioners. Not only are these units the most powerful we have ever developed, but they offer the greatest flexibility for practitioners to treat their patients."

"Since introducing the SolarisPlus devices, demand for capital equipment appears to be picking up," stated Larry K. Beardall, executive vice president of sales and marketing. "We fully expect that the record number of new products being introduced this year will help boost sales even in the face of a flagging economy."

The company plans to introduce additional new products over the coming months and is nearing the completion of its 2013 - 2014 product catalog, which will feature a number of new distributed medical supplies for practitioners.

"We believe that our strategy of introducing new products, combined with our cost reduction program and continued effort with large national accounts, will enable our company to improve its financial results and increase market share," concluded Cullimore.

Dynatronics has scheduled a conference call for investors on Friday, September 28, 2012, at 4:30 p.m. ET. Those wishing to participate should call (800) 616-7436.

The following is a summary of the financial results as of June 30, 2012 and 2011, and for the three-month period and year then ended:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES